Skip to main content
logo
Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.030
-0.145 (-4.57%)
At close: May 7, 2026, 4:00 PM EDT
3.000
-0.030 (-0.98%)
After-hours: May 7, 2026, 7:58 PM EDT

Editas Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2972011058286111,817
Market Cap Growth
129.26%90.94%-87.31%35.64%-66.39%-58.58%
Enterprise Value
190.31119.66-92.03529.56299.271,333
Last Close Price
3.032.051.2710.138.8726.55
PE Ratio
--1.14-0.44-5.01-2.76-9.32
PS Ratio
7.674.953.2510.6030.9871.13
PB Ratio
67.307.350.782.371.693.28
P/TBV Ratio
63.526.670.782.201.693.24
P/FCF Ratio
--1.21-0.48-6.05-3.37-10.58
P/OCF Ratio
--1.21-0.50-6.27-3.44-11.09
EV/Sales Ratio
4.922.95-2.856.7815.1852.19
EV/EBITDA Ratio
--0.770.38-3.25-1.36-7.09
EV/EBIT Ratio
--0.750.37-3.13-1.32-6.90
EV/FCF Ratio
--0.720.42-3.87-1.65-7.76
Debt / Equity Ratio
13.112.410.540.070.090.03
Debt / EBITDA Ratio
-0.68-0.50-0.38-0.22-0.20-0.14
Debt / FCF Ratio
-0.51-0.46-0.42-0.27-0.24-0.15
Net Debt / Equity Ratio
-11.72-2.56-1.32-0.82-0.83-0.85
Net Debt / EBITDA Ratio
0.490.450.721.761.372.52
Net Debt / FCF Ratio
0.370.420.812.091.662.76
Asset Turnover
0.230.150.080.150.030.04
Quick Ratio
3.173.503.715.275.8110.67
Current Ratio
3.223.543.755.395.9410.82
Return on Equity (ROE)
-687.49%-198.14%-98.10%-43.17%-48.22%-40.65%
Return on Assets (ROA)
-64.82%-60.60%-59.75%-33.39%-37.92%-30.90%
Return on Invested Capital (ROIC)
-4550.59%-1280.18%-327.16%-128.92%-160.45%-132.09%
Return on Capital Employed (ROCE)
-87.13%-79.09%-71.73%-38.01%-41.66%-33.74%
Earnings Yield
-36.73%-87.80%-226.77%-19.94%-36.19%-10.73%
FCF Yield
-47.56%-82.66%-208.53%-16.53%-29.72%-9.45%
Buyback Yield / Dilution
-11.90%-7.78%-8.39%-10.63%-1.55%-15.37%
Total Shareholder Return
-11.90%-7.78%-8.39%-10.63%-1.55%-15.37%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q